4th Quarter - Report
AKIN GUMP STRAUSS HAUER & FELD for SUN PHARMA (FORMERLY RANBAXY INC )
Income
$80,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
S. 214, Preserve Access to Affordable Generics Act; implementation of P.L. 111-148, Patient Protection and Affordable Care Act; implementation of P.L. 113-54, Drug Quality and Security Act; 21st Century Cures initiative
| Lobbyist | Covered position, as disclosed |
|---|---|
| KENDALL BYRUM HUSSEY | — |
| JOHN JONAS | — |
| MATTHEW TODD TUTEN | — |
| ANURAG VARMA | — |
Budget/Appropriations BUD
FY 2015 Cromnibus
| Lobbyist | Covered position, as disclosed |
|---|---|
| KENDALL BYRUM HUSSEY | — |
| JOHN JONAS | — |
| MATTHEW TODD TUTEN | — |
| ANURAG VARMA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.